ACR 2019 - Report from Day 2 (Monday)
12 November 2019
Monday was another full day of sessions and studies here in Atlanta. Following is my roundup of day two.
The Safety of Methotrexate
Pegradicase+immTOR SEL-212 Shows Promising Results in Active Gout
12 November 2019
Therapies targeting sUA accumulation or improving its excretion are widely used for treatment of symptoms and prevention of progression of gout for decades.
PANLAR Ultrasound Study Group: Recommendations on Imaging Modalities in Gout
10 November 2019
Gout is a systemic inflammatory disease with high potential for joint damage due to erosive changes and MSU deposits resulting in disability and chronic pain. Prompt diagnosis and effective treatment are key to better long term outcomes and decreased disability.
New EULAR/ACR Classification Criteria for SLE
18 September 2019
The European League Against Rheumatism (EULAR) and the American College of Rheumatology (ACR) have jointly developed new classification criteria for systemic lupus erythematosus (SLE); prompted by the need for criteria that were both highly sensitive and specific.
